Glycopyrrolate and Betapace drug interactions - a phase IV clinical study of FDA data
There is no or too few drug interactions reported by people who take Glycopyrrolate and Betapace together.
The phase IV clinical study analyzes what interactions people have when they take Glycopyrrolate and Betapace. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
No or to few reports are found.
What is Glycopyrrolate?
Glycopyrrolate has active ingredients of glycopyrrolate. It is used in hyperhidrosis. Currently, eHealthMe is studying from 4,884 Glycopyrrolate users.
What is Betapace?
Betapace has active ingredients of sotalol hydrochloride. It is used in atrial fibrillation/flutter. Currently, eHealthMe is studying from 2,872 Betapace users.
Do you take Glycopyrrolate and Betapace?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
Alternative drugs to, pros and cons of the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate and sotalol hydrochloride (the active ingredients of Glycopyrrolate and Betapace, respectively), and Glycopyrrolate and Betapace (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Glycopyrrolate and Betapace.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Implanon and Skin Disorder - 3 seconds ago
- Mycamine and Hyperbilirubinaemia Aggravated - 8 seconds ago
- L-Lysine and Head Injury - 16 seconds ago
- Tecfidera and Type 1 Diabetes - 16 seconds ago
- Adalat and Circulatory Collapse - 24 seconds ago
- Diclofenac Sodium and Kuvan drug interaction - 34 seconds ago
- Valacyclovir and Selenium drug interaction - 43 seconds ago
- Protonix and Esomeprazole Magnesium drug interaction - 45 seconds ago
- Valsartan and Gastrointestinal Motility Disorder - 48 seconds ago
- Progesterone and Catapres-Tts-1 drug interaction - a minute ago